Literature DB >> 19465352

[Microbiological service for intensive care units in Hungary].

Edit Hajdú1, Ria Benko, Mária Matuz, Zoltán Peto, Agnes Hegedus, Gyöngyvér Soós, Lajos Bogár, Erzsébet Nagy.   

Abstract

For the effective treatment of patients with infectious diseases in intensive care units, reliable microbiological diagnoses and correct evaluations of results by expert infectious disease specialists/microbiologists are indispensable. A 97-question survey was conducted about the antibiotic policy, the available background of the microbiological diagnoses and the consultation possibilities in infectious diseases/microbiology at intensive care units in Hungary. Sixty-two percent (60/96) of questionnaires were returned. Of these units, 55% had a microbiological laboratory in-house. Microbiological reports usually serve as basis for the choice of antibiotic treatment. It is an undesirable practice that during working days and during week-ends the proportions of positive microbiological reports sent back to the wards within the optimal time are only 50% and <20%, respectively. Helpful opinion of an expert infectious disease specialist or microbiologist was available in >90% of the cases during working hours, while out of working hours the help of an infectious disease specialist and a microbiologist specialist was available in 70% and 55% of the cases, respectively. Almost half of the units requested the help of an infectious disease specialist whereas only one-third of them turned to a microbiologist. Accordingly, the background for microbiological laboratory diagnoses available for intensive care units is far from optimal in Hungary and is not adequately stipulated in their working conditions.

Entities:  

Mesh:

Year:  2009        PMID: 19465352     DOI: 10.1556/OH.2009.28592

Source DB:  PubMed          Journal:  Orv Hetil        ISSN: 0030-6002            Impact factor:   0.540


  1 in total

1.  Treatment of Cystitis by Hungarian General Practitioners: A Prospective Observational Study.

Authors:  Ria Benko; Maria Matuz; Zoltan Juhasz; Julia Bognar; Reka Bordas; Gyongyver Soos; Edit Hajdu; Zoltan Peto
Journal:  Front Pharmacol       Date:  2019-12-19       Impact factor: 5.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.